Prognostic impact of 1q abnormality on outcomes in patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone in a real-world clinical setting

Saved in:
Bibliographic Details
Published inAnnals of hematology Vol. 103; no. 9; pp. 3811 - 3813
Main Authors Kikuchi, Taku, Tsukada, Nobuhiro, Kunisada, Kodai, Matsumoto, Chiaki, Nomura-Yogo, Moe, Oda, Yuki, Sato, Kota, Takei, Tomomi, Ogura, Mizuki, Abe, Yu, Suzuki, Kenshi, Hosoya, Osamu, Ishida, Tadao
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.09.2024
Springer Nature B.V
Subjects
Correspondence
Hematology
Medicine
Medicine & Public Health
Oncology
Online AccessGet full text

Cover

More Information
Bibliography:content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ISSN:0939-5555
1432-0584
1432-0584
DOI:10.1007/s00277-024-05835-4